Brief: Oncodesign Precision Medicine, Navigo Proteins GmbH Sign Strategic Collaboration Agreement
15/05/2024 17:36
May 15 (Reuters) - Oncodesign Precision Medicine Opm SA
ALOPM.PA :
* ONCODESIGN PRECISION MEDICINE AND NAVIGO PROTEINS GMBH
SIGN A
STRATEGIC COLLABORATION AGREEMENT FOR THE RESEARCH AND
DEVELOPMENT OF NEW SYSTEMIC RADIOTHERAPY AGENTS
Source text for Eikon: ID:nBw3v08pna
Further company coverage: ALOPM.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))